Scott E Gygax

This inventor holds 10 USPTO granted patents and 1 published patent application. Top assignees: Medical Diagnostic Laboratories, LLC, Other. Active years: 2011-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott E Gygax. Retrieved from https://idiyas.com/inventor/scott-e-gygax

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 1)

% Patents Active = 40.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)

Location History:

Yardely, PA (US) (2014)
Bordentown, NJ (US) (2011 - 2018)
Yardley, PA (US) (2014 - 2020)

Company Filing History:

9 out of 80

Medical Diagnostic Laboratories, LLC

patents

1 out of 834,570

Other

patents

Years Active: 2011-2020

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10829826 - Single nucleotide polymorphisms and community-associated methicillin-resistant (2020-11-10),

2. 10221462 - [object Object] (2019-03-05),

3. 10041130 - [object Object] (2018-08-07),

4. 9738938 - [object Object] (2017-08-22),

5. 9593384 - Metronidazole resistance in trichomonas vaginalis and single nucleotide polymorphisms (2017-03-14),

6. 9297048 - [object Object] (2016-03-29),

7. 8741563 - Metronidazole resistance in trichomonas vaginalis and single nucleotide polymorphisms (2014-06-03),

8. 8715936 - [object Object] (2014-05-06),

9. 8247170 - [object Object] (2012-08-21),

10. 8021846 - [object Object] (2011-09-20),

Title: Scott E Gygax: Innovator in Medical Diagnostics

Introduction

Scott E Gygax is a prominent inventor based in Yardley, PA (US), known for his significant contributions to the field of medical diagnostics. With a total of 10 patents to his name, Gygax has made remarkable advancements in identifying and understanding genetic markers associated with diseases.

Latest Patents

Among his latest patents, Gygax has focused on single nucleotide polymorphisms (SNPs) related to community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). His invention revolves around the discovery of novel polymorphisms in the penicillin binding protein (pbp3) gene. The presence of G88A and/or G2047A SNPs serves as a reliable biomarker for detecting CA-MRSA. This invention provides essential reagents for detecting these SNPs and outlines methods for screening biological samples, particularly from humans, to identify the presence of CA-MRSA.

Career Highlights

Gygax has worked with Medical Diagnostic Laboratories, LLC, where he has applied his expertise in genetic diagnostics. His work has contributed to the development of innovative methods for disease detection, enhancing the accuracy and reliability of medical diagnostics.

Collaborations

Throughout his career, Gygax has collaborated with notable professionals, including Martin E Adelson and Eli Mordechai. These collaborations have further enriched his research and development efforts in the field of medical diagnostics.

Conclusion

Scott E Gygax stands out as a key figure in the realm of medical diagnostics, with his innovative patents paving the way for improved disease detection methods. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent pending: